Some consider trade shows to be a necessary evil — be seen or be gone. Others see them as a great tool in their marketing kit. They are a really a combination of both. As we re-enter a more customary world of MedTech tradeshows and events, it may be useful to look at why we attend them in the first place.

An interview with our partners Larry Barr, Göran Brorsson, and Chuck Weikel discussing the first half of 2021 in the MedTech M&A markets.

Our partners Larry Barr, Göran Brorsson, and Chuck Weikel sat down to discuss the state of MedTech M&A and expectations for the new year.